Literature DB >> 8502543

Deprotection of methylphosphonate oligonucleotides using a novel one-pot procedure.

R I Hogrefe1, M M Vaghefi, M A Reynolds, K M Young, L J Arnold.   

Abstract

Deprotection of methylphosphonate oligonucleotides with ethylenediamine was evaluated in a model system. Methylphosphonate sequences of the form 5'-TTTNNTTT, where N was either N4-bz-dC, N4-ibu-dC, N2-ibu-O6-DPC-dG, N2-ibu-dG, N6-bz-dA, or T, were used to determine the extent of modifications that occur during deprotection. Up to 15% of N4-bz-dC was found to transaminate at the C4 position when treated with ethylenediamine. A similar displacement reaction with ethylenediamine was observed at the O6 position of N2-ibu-O6-DPC-dG, and to a much lesser extent of N2-ibu-dG. Side reactions were not observed when oligonucleotides containing N4-ibu-dC, N6-bz-dA, or T were treated with ethylenediamine. A novel method of deprotecting methylphosphonate oligonucleotides was developed from these studies. The method incorporates a brief treatment with dilute ammonia for 30 minutes followed by addition of ethylenediamine for 6 hours at room temperature to complete deprotection in a one-pot format. The solution is then diluted and neutralized to stop the reaction and prepare the crude product for chromatographic purification. This method was used to successfully deprotect a series of oligonucleotides at the 1, 100, and 150 mumole scales. These deprotection results were compared to a commonly used two-step method and found to be superior in yield of product by as much as 250%.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8502543      PMCID: PMC309461          DOI: 10.1093/nar/21.9.2031

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  16 in total

1.  Site specificity of the inhibitory effects of oligo(nucleoside methylphosphonate)s complementary to the acceptor splice junction of herpes simplex virus type 1 immediate early mRNA 4.

Authors:  M Kulka; C C Smith; L Aurelian; R Fishelevich; K Meade; P Miller; P O Ts'o
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

Review 2.  Oligonucleoside methylphosphonates as antisense reagents.

Authors:  P S Miller
Journal:  Biotechnology (N Y)       Date:  1991-04

Review 3.  Antisense oligodeoxynucleotides as antiviral agents.

Authors:  J S Cohen
Journal:  Antiviral Res       Date:  1991-09       Impact factor: 5.970

Review 4.  Antisense agents in cancer research and therapeutics.

Authors:  B J Dolnick
Journal:  Cancer Invest       Date:  1991       Impact factor: 2.176

5.  Antisense inhibition of ras p21 expression that is sensitive to a point mutation.

Authors:  E H Chang; P S Miller; C Cushman; K Devadas; K F Pirollo; P O Ts'o; Z P Yu
Journal:  Biochemistry       Date:  1991-08-27       Impact factor: 3.162

6.  Modulation of drug resistance in a daunorubicin resistant subline with oligonucleoside methylphosphonates.

Authors:  G Vasanthakumar; N K Ahmed
Journal:  Cancer Commun       Date:  1989

7.  Synthesis and enzymatic properties of deoxyribooligonucleotides containing methyl and phenylphosphonate linkages.

Authors:  K L Agarwal; F Riftina
Journal:  Nucleic Acids Res       Date:  1979-07-11       Impact factor: 16.971

8.  Inhibition of human immunodeficiency virus by using an oligonucleoside methylphosphonate targeted to the tat-3 gene.

Authors:  J A Zaia; J J Rossi; G J Murakawa; P A Spallone; D A Stephens; B E Kaplan; R Eritja; R B Wallace; E M Cantin
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

9.  Comparative hybrid arrest by tandem antisense oligodeoxyribonucleotides or oligodeoxyribonucleoside methylphosphonates in a cell-free system.

Authors:  L J Maher; B J Dolnick
Journal:  Nucleic Acids Res       Date:  1988-04-25       Impact factor: 16.971

10.  Synthetic oligonucleotides as therapeutic agents.

Authors:  D M Tidd
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

View more
  20 in total

1.  Hydroquinone-O,O'-diacetic acid ('Q-linker') as a replacement for succinyl and oxalyl linker arms in solid phase oligonucleotide synthesis.

Authors:  R T Pon; S Yu
Journal:  Nucleic Acids Res       Date:  1997-09-15       Impact factor: 16.971

2.  Polyamine-assisted rapid and clean cleavage of oligonucleotides from cis-diol bearing universal support.

Authors:  P Kumar; G Dhawan; R Chandra; K C Gupta
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

3.  Design and calibration of a semi-synthetic DNA phasing assay.

Authors:  P R Hardwidge; J M Zimmerman; L J Maher
Journal:  Nucleic Acids Res       Date:  2000-12-01       Impact factor: 16.971

4.  Processing of nontelomeric 3' ends by telomerase: default template alignment and endonucleolytic cleavage.

Authors:  M Melek; E C Greene; D E Shippen
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

5.  Effects of phosphate neutralization on the shape of the AP-1 transcription factor binding site in duplex DNA.

Authors:  L A Tomky; J K Strauss-Soukup; L J Maher
Journal:  Nucleic Acids Res       Date:  1998-05-15       Impact factor: 16.971

6.  Developmentally regulated initiation of DNA synthesis by telomerase: evidence for factor-assisted de novo telomere formation.

Authors:  J Bednenko; M Melek; E C Greene; D E Shippen
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

7.  Antisense oligonucleotide containing an internal, non-nucleotide-based linker promote site-specific cleavage of RNA.

Authors:  M A Reynolds; T A Beck; P B Say; D A Schwartz; B P Dwyer; W J Daily; M M Vaghefi; M D Metzler; R E Klem; L J Arnold
Journal:  Nucleic Acids Res       Date:  1996-02-15       Impact factor: 16.971

8.  Determination of optimal sites of antisense oligonucleotide cleavage within TNFalpha mRNA.

Authors:  B H Lloyd; R V Giles; D G Spiller; J Grzybowski; D M Tidd; D R Sibson
Journal:  Nucleic Acids Res       Date:  2001-09-01       Impact factor: 16.971

9.  The application of the AMB protective group in the solid-phase synthesis of methylphosphonate DNA analogues.

Authors:  W H Kuijpers; E Kuyl-Yeheskiely; J H van Boom; C A van Boeckel
Journal:  Nucleic Acids Res       Date:  1993-07-25       Impact factor: 16.971

10.  On the rapid deprotection of synthetic oligonucleotides and analogs.

Authors:  N N Polushin; A M Morocho; B C Chen; J S Cohen
Journal:  Nucleic Acids Res       Date:  1994-02-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.